HLN 6-K
Haleon plc (HLN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2025
Commission File Number: 001-41411
Haleon plc
(Translation of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F<br>☒ | Form 40-F<br>☐ |
|---|
EXHIBIT INDEX
| Exhibit<br>Number | Description |
|---|---|
| 99.1 | 28 May<br>2025 - Results of Haleon 2025 Annual General Meeting |
99.1
Haleon plc: Results of Haleon 2025 Annual General Meeting
28 May 2025: Haleon plc (the "Company" or "Haleon) (LSE/NYSE: HLN) announces that the following resolutions were decided by poll vote at the Company's 2025 Annual General Meeting ("AGM") which was held today.
Resolutions 19, 20, 21 and 22 were passed as special resolutions; all other resolutions were passed as ordinary resolutions. Full text of the resolutions is contained in the Company's Notice of AGM, which is available at www.haleon.com.
Haleon plc - Poll Results
| Resolution | Votes for | For (% of shares voted) | Votes against | Against (% of shares voted) | Total votes cast (excluding withheld) | % of issued share capital<br>voted1 | Votes withheld2 | |
|---|---|---|---|---|---|---|---|---|
| 1 | To receive the Annual Report & Accounts | 7,517,144,325 | 99.99 | 842,368 | 0.01 | 7,517,986,693 | 83.48 | 65,369,244 |
| 2 | To approve the Directors' Remuneration Report | 7,428,243,215 | 98.73 | 95,579,831 | 1.27 | 7,523,823,046 | 83.54 | 59,533,076 |
| 3 | To declare a final dividend | 7,524,186,981 | 99.99 | 923,515 | 0.01 | 7,525,110,496 | 83.56 | 58,245,442 |
| 4 | To re-elect Sir Dave Lewis | 7,498,843,821 | 99.66 | 25,860,104 | 0.34 | 7,524,703,925 | 83.55 | 58,652,013 |
| 5 | To re-elect Brian McNamara | 7,522,242,013 | 99.97 | 2,587,699 | 0.03 | 7,524,829,712 | 83.55 | 58,526,226 |
| 6 | To elect Dawn Allen | 7,483,140,783 | 99.45 | 41,558,848 | 0.55 | 7,524,699,631 | 83.55 | 58,654,043 |
| 7 | To re-elect Manvinder Singh (Vindi) Banga | 7,519,740,136 | 99.94 | 4,786,625 | 0.06 | 7,524,526,761 | 83.55 | 58,829,175 |
| 8 | To elect Nancy Avila | 7,516,944,426 | 99.90 | 7,674,923 | 0.10 | 7,524,619,349 | 83.55 | 58,736,587 |
| 9 | To re-elect Marie-Anne Aymerich | 7,516,731,352 | 99.91 | 6,797,652 | 0.09 | 7,523,529,004 | 83.54 | 59,826,931 |
| 10 | To elect Bláthnaid Bergin | 7,520,233,253 | 99.94 | 4,257,800 | 0.06 | 7,524,491,053 | 83.55 | 58,864,884 |
| 11 | To re-elect Tracy Clarke | 7,500,339,471 | 99.68 | 24,261,558 | 0.32 | 7,524,601,029 | 83.55 | 58,754,908 |
| 12 | To re-elect Dame Vivienne Cox | 7,509,748,919 | 99.80 | 14,871,809 | 0.20 | 7,524,620,728 | 83.55 | 58,731,806 |
| 13 | To re-elect Asmita Dubey | 7,510,543,577 | 99.81 | 14,014,288 | 0.19 | 7,524,557,865 | 83.55 | 58,798,072 |
| 14 | To elect Alan Stewart | 7,522,008,446 | 99.97 | 2,330,160 | 0.03 | 7,524,338,606 | 83.55 | 59,005,235 |
| 15 | To re-appoint KPMG as auditor of the Company | 7,521,601,516 | 99.95 | 3,522,152 | 0.05 | 7,525,123,668 | 83.56 | 58,232,270 |
| 16 | To authorise the Audit & Risk Committee to set the auditor's<br>remuneration | 7,522,283,299 | 99.97 | 2,583,886 | 0.03 | 7,524,867,185 | 83.55 | 58,488,752 |
| 17 | To authorise the Company to make political donations | 7,440,921,749 | 98.88 | 84,625,992 | 1.12 | 7,525,547,741 | 83.56 | 57,811,937 |
| 18 | To authorise the Directors to allot ordinary shares | 7,187,533,051 | 95.52 | 336,762,607 | 4.48 | 7,524,295,658 | 83.55 | 59,060,278 |
| 19 | General authority to disapply pre-emption rights | 7,213,281,442 | 95.88 | 309,833,429 | 4.12 | 7,523,114,871 | 83.53 | 60,241,065 |
| 20 | Additional authority to disapply pre-emption rights | 7,039,904,846 | 93.58 | 483,263,460 | 6.42 | 7,523,168,306 | 83.53 | 60,187,475 |
| 21 | To authorise a 14-day notice period for general<br>meetings | 6,957,683,132 | 92.46 | 566,988,704 | 7.54 | 7,524,671,836 | 83.55 | 58,684,099 |
| 22 | To authorise the Company to purchase its own shares | 7,516,118,031 | 99.92 | 5,793,689 | 0.08 | 7,521,911,720 | 83.52 | 61,444,405 |
1 For the purposes of section 341 of the Companies Act 2006, as at 6:30pm (BST) on Friday 23 May 2025, Haleon's issued share capital was 9,010,139,389 ordinary shares of £0.01 each, 4,080,205 of which were held as treasury shares. Therefore, the total voting rights in the Company were 9,006,059,184.
2 A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
As required by the UK Listing Rule 6.4.2R of the Financial Conduct Authority ("FCA"), copies of resolutions passed by the Company other than resolutions concerning ordinary business have been submitted to the FCA via the National Storage Mechanism and will shortly be available to the public for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HALEON PLC<br><br><br>(Registrant) | |||
|---|---|---|---|
| Date:<br>May 28, 2025 | By: | /s/<br>Amanda Mellor | |
| Name: | Amanda<br>Mellor | ||
| Title: | Company<br>Secretary |